SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — George H. W. Bush — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeorge H. W. Bush
Date of birth1924-06-12
IdentifiersMRN HR-ML018-SYN-TD; SSN (made up) 000-18-7245
Document date1991-09-11
AuthorDouglas Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-month review: levothyroxine dose and the anticoagulation decision. [S]

History of Present Illness

Mr. Bush returns eight weeks after starting levothyroxine 75 mcg daily. His tiredness and constipation are better, and he feels cold only occasionally. He took metoprolol 25 mg daily for eight weeks and finished the taper this week. He wore the 14-day ECG patch for the two weeks ending four days ago, with no palpitations. He takes apixaban twice daily with no bleeding. He runs three miles four days a week without symptoms and has regained his usual weight. He takes levothyroxine alone on an empty stomach each morning. [S]

ElementDetail
Thyroid symptomsTiredness and constipation better; occasionally cold
RhythmNo palpitations; 14-day patch completed
MedicinesLevothyroxine 75 mcg daily; metoprolol taper completed; apixaban twice daily
ActivityRunning three miles four days a week

Review of Systems

SystemResultFinding
ConstitutionalPositiveOccasionally cold; energy nearly back to normal; weight back to his usual
CardiovascularNegativeNo palpitations, chest pain, or lightheadedness
GastrointestinalNegativeBowels regular
HematologicNegativeNo bleeding or bruising

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metoprolol succinate extended-release 50 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet each morningOral route1991-05-05 to 1991-07-17stoppedS
Metoprolol succinate extended-release 25 mg oral tablet, one tablet by mouth daily (taper)One tablet each morning for eight weeks, then stopOral route1991-07-17 to 1991-09-11stoppedS
Apixaban 5 mg oral tablet, one tablet by mouth twice daily (started in hospital)One tablet twice dailyOral route1991-05-05 to 1991-09-11stoppedS
Methimazole 10 mg oral tablet, two tablets (20 mg) by mouth dailyTwo tablets once daily; stop three days before radioactive iodineOral route1991-05-08 to 1991-05-26completedS
Levothyroxine 75 mcg oral tablet, one tablet by mouth daily before breakfastOne tablet on an empty stomach 30 to 60 minutes before breakfastOral route1991-07-17 to 1991-09-11stoppedS
Levothyroxine 100 mcg oral tablet, one tablet by mouth daily before breakfastOne tablet on an empty stomach 30 to 60 minutes before breakfastOral route1991-09-11activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1991-09-11Body height188cmS
1991-09-11Body weight90.2kgS
1991-09-11Body mass index (BMI) [Ratio]25.5kg/m2S
1991-09-11Systolic blood pressure126mm[Hg]S
1991-09-11Diastolic blood pressure76mm[Hg]S
1991-09-11Heart rate62/minS
1991-09-11Respiratory rate14/minS
1991-09-11Body temperature36.6CelS
1991-09-11Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1991-09-11Thyrotropin [Units/volume] in Serum or Plasma6.4m[IU]/L0.4-4 mIU/LHighS
1991-09-11Thyroxine (T4) free [Mass/volume] in Serum or Plasma0.9ng/dL0.8-1.8 ng/dLNormalS

Physical Exam

Vital signs recorded on 1991-09-11; see the Vital Signs section. [S]

SystemFinding
GeneralWell and fit
NeckSmall, non-tender thyroid
CardiovascularRegular rhythm at 62 per minute; no murmur
NeurologicalReflexes normal

Problems

ProblemClinical statusVerificationCodeProvenance
Paroxysmal atrial fibrillation, first detected four days before intake while running, triggered by hyperthyroidism; CHA2DS2-VASc 1; synthetic modern episode linked to his documented atrial fibrillationactiveconfirmed I48.0S — Synthetic modern classification of a documented arrhythmia.
Graves' disease with hyperthyroidism; synthetic modern diagnosis linked to his documented Graves' diseaseactiveconfirmed E05.00S — Synthetic modern diagnosis confirmed by thyroid tests and TSH receptor antibody; the historical diagnosis is D.
Hypothyroidism after radioactive iodine, on levothyroxine replacementactiveconfirmed E89.0S — Synthetic modern diagnosis linked to his documented hypothyroidism and lifelong thyroid hormone.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationHeart rate and rhythmEvery visitCompleted today62 per minute, regular, off metoprolol
ExaminationBlood pressureEvery visit; target below 130/80Completed today126/76 mmHg
ExaminationWeight and BMIEvery visitCompleted today90.2 kg, BMI 25.5; back to his usual weight
SurveyAtrial fibrillation symptomsEvery visitCompleted todayNone
ImagingAmbulatory rhythm monitoringAs symptoms or decisions requireCompleted today14-day ECG patch: sinus rhythm throughout; no atrial fibrillation or flutter
SurveyCHA2DS2-VASc and HAS-BLEDYearly and with any change in clinical statusCompleted todayReassessed for the anticoagulation decision: CHA2DS2-VASc 1, HAS-BLED 1
Medication safetyAnticoagulation decisionWith any change in clinical statusCompleted todayApixaban stopped by shared decision after sustained sinus rhythm with the trigger treated
LaboratoryCreatinine and eGFR on apixabanAt baseline and at least yearlyNot indicatedApixaban stopped today
Self-managementAlcohol, tobacco, and physical activityEvery visitCompleted todayAlcohol rarely; never used tobacco; running about 200 minutes a week
SurveySleep apnea symptom screenAt diagnosis and at least yearlyUp to dateNegative two months ago
LaboratoryTSH after a levothyroxine dose changeFour to eight weeks after each dose changeCompleted todayTSH 6.4 mIU/L, free T4 0.9 ng/dL, eight weeks after starting 75 mcg
SurveyHypothyroid and overtreatment symptomsEvery visit during titrationCompleted todayMild residual cold intolerance; no palpitations, tremor, or weight loss
LaboratoryTSH at six months once stable, then yearlyAfter the dose is stableDueDose changed today; TSH in six weeks first

Goal progress:

Guideline basis: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (2023); Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014); CMID: Clinical Monitoring Intelligence Database, atrial fibrillation and hypothyroidism monographs (2026)

Follow-up: TSH in six weeks; annual wellness visit next month. Next scheduled visit 1991-10-16: subsequent annual wellness visit. [S]